Evaluation of the effect of Elaeagnus angustifolia in patients with mild to moderate Benign Prostatic Hyperplasia symptom

Phase 3

• Conditions: Benign prostatic hyperplasia.; Benign neoplasm of prostate; D29.1

• Registration Number: IRCT20150622022869N8
• Lead Sponsor: Yasouj University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 November 2021

Recruitment & Eligibility

• Status: Complete
• Sex: Male
• Target Recruitment: 96

Inclusion Criteria

A patient with a diagnosis of benign prostatic hyperplasia with an IPSS score below 21

Exclusion Criteria

Patients with a diagnosis of BPH with an IPSS score above 21

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
IPSS (International prostate symptom score)questionnaire score. Timepoint: At the beginning of the study and 30 dimensions, the IPSS (International prostate symptom score)questionnaire is filled out for patients (at the same time as the end of the capsules). Method of measurement: IPSS (International prostate symptom score).